{"result": "(\"entity\"<|>PREDIMED STUDY<|>EVENT<|>The PREDIMED Study is a nutrition intervention trial focused on the Mediterranean diet and its effects on cardiovascular health.)\n##\n(\"entity\"<|>MEDITERRANEAN DIET<|>EVENT<|>The Mediterranean diet is a dietary pattern characterized by high consumption of fruits, vegetables, whole grains, and healthy fats, particularly olive oil, which is associated with various health benefits.)\n##\n(\"entity\"<|>ANN INTERN MED<|>ORGANIZATION<|>Ann Intern Med is a medical journal that publishes research articles, including studies on dietary impacts on health.)\n##\n(\"entity\"<|>BMC MED<|>ORGANIZATION<|>BMC Med is a peer-reviewed medical journal that publishes research articles related to various aspects of medicine, including nutrition and cardiovascular health.)\n##\n(\"entity\"<|>CIRCULATION<|>ORGANIZATION<|>Circulation is a scientific journal that publishes research on cardiovascular medicine and health.)\n##\n(\"entity\"<|>LANCET<|>ORGANIZATION<|>Lancet is a leading medical journal that publishes research and reviews on various health topics, including cardiovascular diseases.)\n##\n(\"entity\"<|>EFSA<|>ORGANIZATION<|>The European Food Safety Authority (EFSA) is an agency that provides scientific advice on food safety and nutrition in the European Union.)\n##\n(\"entity\"<|>GUASCH-FERRÉ M<|>PERSON<|>Guasch-Ferré M is a researcher involved in studies related to the Mediterranean diet and its effects on health.)\n##\n(\"entity\"<|>BULLÓ M<|>PERSON<|>Bulló M is a researcher who has contributed to studies on the Mediterranean diet and cardiovascular health.)\n##\n(\"entity\"<|>ESTRUCH R<|>PERSON<|>Estruch R is a researcher known for his work on the Mediterranean diet and its health benefits.)\n##\n(\"relationship\"<|>GUASCH-FERRÉ M<|>PREDIMED STUDY<|>Guasch-Ferré M is a researcher associated with the PREDIMED Study, contributing to its findings<|>8)\n##\n(\"relationship\"<|>BULLÓ M<|>PREDIMED STUDY<|>Bulló M is a researcher associated with the PREDIMED Study, contributing to its findings<|>8)\n##\n(\"relationship\"<|>ESTRUCH R<|>PREDIMED STUDY<|>Estruch R is a researcher associated with the PREDIMED Study, contributing to its findings<|>8)\n##\n(\"relationship\"<|>ANN INTERN MED<|>PREDIMED STUDY<|>The PREDIMED Study was published in Ann Intern Med, indicating a relationship between the study and the journal<|>7)\n##\n(\"relationship\"<|>BMC MED<|>PREDIMED STUDY<|>The PREDIMED Study was published in BMC Med, indicating a relationship between the study and the journal<|>7)\n##\n(\"relationship\"<|>CIRCULATION<|>PREDIMED STUDY<|>Research findings from the PREDIMED Study may be discussed in Circulation, indicating a relationship<|>6)\n##\n(\"relationship\"<|>LANCET<|>PREDIMED STUDY<|>Research findings from the PREDIMED Study may be discussed in Lancet, indicating a relationship<|>6)\n##\n(\"relationship\"<|>EFSA<|>MEDITERRANEAN DIET<|>EFSA provides scientific advice on dietary patterns, including the Mediterranean diet, indicating a relationship<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Salas-Salvadó J, Bulló M, Estruch R, et al. Preven-\n      ma RA, Delgado-Rodríguez M, et al. Adipose tis-                      tion of diabetes with Mediterranean diets: a sub-\n---\n                          Tema 19.      Influencia de la dieta en el control de la hiperlipemia y el riesgo cardiovascular                    341\n\n\n\n     group analysis of a randomized trial. Ann Intern                              polyunsaturated fatty acids, monounsaturated fa-\n     Med. 2014; 160: 1-10.                                                         tty acids, trans fatty acids, and cholesterol. EFSA J\n40.  Doménech M, Roman P, Lapetra J, et al. Mediterra-                             2010; 8(3): 1461.\n     nean diet reduces 24-hour ambulatory blood pres-                        53.   Connor WE. Importance of n-3 fatty acids in heal-\n     sure, blood glucose, and lipids: one-year randomi-                            th and disease. Am J Clin Nutr 2000; 71 (suppl):\n     zed, clinical trial. Hypertension. 2014; 64: 69-76.                           171S-5S.\n41.  Guasch-Ferré M, Hu FB, Martínez-González MA,                            54.   Dietary supplementation with n-3 polyunsaturated\n     Fitó M, Bulló M, Estruch R,           et al. Olive oil intake                 fatty acids and vitamin E after myocardial infarction:\n     and risk of cardiovascular disease and mortality in                           results of the GISSI-Prevenzione trial. Gruppo Italia-\n     the PREDIMED Study. BMC Med. 2014; 12:78.                                     no per lo Studio della Sopravvivenza nell’Infarto\n42.  Tresserra-Rimbau A, Rimm EB, Medina-Remón A,                                  miocardico. Lancet. 1999; 354:447-55.\n     Martínez-González MA, de la Torre R, Corella D,                         55.   Yokoyama M, Origasa H, Matsuzaki M,                      et al.\n     et    al.   Inverse    association      between        habitual               Effects of eicosapentaenoic acid on major coro-\n     polyphenol intake and incidence of cardiovascular                             nary    events    in   hypercholesterolaemic          patients\n     events in the PREDIMED study. Nutr Metab Car-                                 (JELIS):   a  randomised        open-label,      blinded    en-\n     diovasc Dis. 2014 Jun; 24(6):639-47.                                          dpoint analysis. Lancet. 2007; 369:1090-8.\n43.  Ros E, Hu FB. Consumption of plant seeds and car-                       56.   Rauch B, Schiele R, Schneider S, et al. OMEGA, a\n     diovascular      health:   epidemiological        and   clinical              randomized, placebo-controlled trial to test the\n     trial evidence. Circulation. 2013; 128: 553-65.                               effect of highly purified omega-3 fatty acids on\n44.  Guasch-Ferré M, Bulló M, Martínez-González MÁ,                                top of modern guideline-adjusted therapy after\n     Ros E, Corella D, Estruch R, et al. Frequency of nut                          myocardial         infarction.       Circulation.        2010;\n     consumption and mortality risk in the PREDIMED                                122:2152-9.\n     nutrition intervention trial. BMC Med. 2013; 11:164.                    57.   Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty\n45.  Farvid MS, Ding M, Pan A,             et al.  Dietary linoleic                acids and cardiovascular events after myocardial\n     acid and risk of coronary heart disease: A systema-                           infarction. N Engl J Med. 2010; 363: 2015-26.\n     tic review and meta-analysis of prospective cohort                      58.   Galan P, Kesse-Guyot E, Czernichow S, Briancon S,\n     studies. Circulation. 2014; 130:1568-78.                                      Blacher J, Hercberg S. Effects of B vitamins and\n46.  Burdge G. alpha-Linolenic acid metabolism in men                              omega 3 fatty acids on cardiovascular diseases: a\n     and women: nutritional and biological implica-                                randomised placebo controlled trial. BMJ. 2010;\n     tions. Curr Opin Clin Nutr Metabol Care 2004; 7:                              341:c6273.\n     137-44.                                                                 59.   Roncaglioni MC, Tombesi M, Avanzini F, et al. n-3\n47.  De Lorgeril M, Renaud S, Mamelle N, Salen P, Mar-                             fatty acids in patients with multiple cardiovascular\n     tin JL, Monjaud I, et al. Mediterranean alpha-lino-                           risk factors. N Engl J Med. 2013; 368:1800-8.\n     leic acid-rich diet in secondary prevention of coro-                    60.   Sala-Vila A, Guasch-Ferré M\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}